NSETrading Window26 Jun 2026 · 26 Jun 2026, 04:53 pm

Trading Window

Suven Life Sciences Limited · SUVEN

✦ AI SummaryResults

Suven Life Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window for dealing in securities of the Company will remain closed from July 1, 2026, till the end of 48 hours after the declaration of un-audited Financial Results for the quarter ended June 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Suven Life Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Attachments (1)

📄

SUVEN_26062026165241_TWSuven26062026.pdf

pdf

Download →
View document text
CSD/BSE&NSE/TW/2026-27 Date: 26th June, 2026 To To The General Manager The Manager Department of Corporate Services Listing Department BSE Limited National Stock Exchange of India Limited 25th Floor, P. J. Towers, Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai - 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 530239 Scrip Symbol: SUVEN Dear Sir/Madam, Sub: Intimation of Closure of Trading Window Pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the Company’s Code of Conduct to regulate, monitor and report trading of designated persons, the ‘Trading Window’ for dealing in securities of the Company for all the designated persons and their immediate relatives, Connected Persons (including their relatives) as covered under the said code shall remain close with effect from July 1, 2026, till the end of 48 hours after the declaration of un-audited Financial Results for the quarter ended June 30, 2026. Accordingly, all Designated Persons of the Company are being advised not to trade in the securities of the Company during the aforesaid period of closure of the Trading Window. Please note that the date of the Board Meeting to be held for consideration of un-audited financial results of the Company for quarter ended June 30, 2026, shall be communicated in due course. This is for your information and records. Thanking you, Yours faithfully, For Suven Life Sciences Limited K. Sangeetha Laxmi Company Secretary & Compliance Officer Suven Life Sciences Limited Registered Office: 8-2-334 I SDE Serene Chambers I 6th Floor Road No.5 I Avenue 7 Banjara Hills I Hyderabad – 500 034 I Telangana I India I CIN: L24110TG1989PLC009713 Tel: 91 40 2354 1142/ 1152 Email: info@suven.com website: www.suven.com